播恩集团：全资子公司广州八维生物技术有限公司拟向控股股东转让房产

Group 1 - The core point of the article is that Boen Group announced a property transfer agreement involving its wholly-owned subsidiary, Guangzhou Bawen Biotechnology Co., Ltd., to its controlling shareholder, Jiangxi Bawen Biotechnology Group Co., Ltd., for a transaction amount of 18.904 million yuan (including tax) [1] - For the first half of 2025, Boen Group's revenue composition is entirely from the feed industry, accounting for 100.0% [1] - As of the report date, Boen Group has a market capitalization of 2.1 billion yuan [1]